Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Nordestgaard

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
HIV Medicine|August 31, 2018
Diagnostic performance of clinical characteristics to detect airflow limitation in people living with HIV and in uninfected controlsA Ronit, T Benfield, A Mocroft, et al.
Atherosclerosis|February 13, 2001
Apolipoprotein E genotypes predict attendance rates at lipid clinicR Frikke-Schmidt, H H Wittrup, A Tybjaerg-Hansen, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2001
Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart StudyA A Sethi, B G Nordestgaard, B Agerholm-Larsen, et al.
The Journal of Clinical Investigation|June 15, 1997
A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart StudyA Tybjaerg-Hansen, B Agerholm-Larsen, S E Humphries, et al.
Journal of Internal Medicine|January 5, 2011
Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-upA Langsted, J J Freiberg, A Tybjaerg-Hansen, et al.
Circulation|May 20, 1997
ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart StudyB Agerholm-Larsen, B G Nordestgaard, R Steffensen, et al.
Annals of Internal Medicine|May 16, 2001
Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart StudyA A Sethi, A Tybjaerg-Hansen, M L Grønholdt, et al.
The Pharmacogenomics Journal|June 2, 2010
Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general populationM S Nørskov, R Frikke-Schmidt, S E Bojesen, et al.
Annals of Internal Medicine|September 1, 1997
ACE gene polymorphism as a risk factor for ischemic cerebrovascular diseaseB Agerholm-Larsen, A Tybjaerg-Hansen, R Frikke-Schmidt, et al.
The European Respiratory Journal|July 5, 2005
The protease inhibitor PI*S allele and COPD: a meta-analysisM Dahl, C P Hersh, N P Ly, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
HIV Medicine|August 31, 2018
Diagnostic performance of clinical characteristics to detect airflow limitation in people living with HIV and in uninfected controlsA Ronit, T Benfield, A Mocroft, et al.
Atherosclerosis|February 13, 2001
Apolipoprotein E genotypes predict attendance rates at lipid clinicR Frikke-Schmidt, H H Wittrup, A Tybjaerg-Hansen, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2001
Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart StudyA A Sethi, B G Nordestgaard, B Agerholm-Larsen, et al.
The Journal of Clinical Investigation|June 15, 1997
A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart StudyA Tybjaerg-Hansen, B Agerholm-Larsen, S E Humphries, et al.
Journal of Internal Medicine|January 5, 2011
Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-upA Langsted, J J Freiberg, A Tybjaerg-Hansen, et al.
Circulation|May 20, 1997
ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart StudyB Agerholm-Larsen, B G Nordestgaard, R Steffensen, et al.
Annals of Internal Medicine|May 16, 2001
Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart StudyA A Sethi, A Tybjaerg-Hansen, M L Grønholdt, et al.
The Pharmacogenomics Journal|June 2, 2010
Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general populationM S Nørskov, R Frikke-Schmidt, S E Bojesen, et al.
Annals of Internal Medicine|September 1, 1997
ACE gene polymorphism as a risk factor for ischemic cerebrovascular diseaseB Agerholm-Larsen, A Tybjaerg-Hansen, R Frikke-Schmidt, et al.
The European Respiratory Journal|July 5, 2005
The protease inhibitor PI*S allele and COPD: a meta-analysisM Dahl, C P Hersh, N P Ly, et al.
Pageof 13